Why the study?
Arterial thrombosis is an increasingly recognized serious complication of cancer and chemotherapeutic agents, with cisplatin frequently linked to acute vascular events.
Cisplatin-based chemotherapy may cause rare but severe arterial thrombosis, necessitating careful monitoring and prompt management.
Thromboembolism is a significant cause of mortality and morbidity in cancer patients. While the link between cancer and venous thrombosis is well known, the recognition of arterial thrombosis as a serious complication of cancer and chemotherapeutic agents is a recent development. One of the chemotherapy agents frequently linked to acute vascular events is cisplatin. We discuss a rare case of cisplatin-related brachial arterial thrombosis in a 50-year-old man who was treated for cholangiocarcinoma with cisplatin and gemcitabine. Although rare, cisplatin-related arterial thrombosis demands careful monitoring, a high index of suspicion, and prompt management to prevent serious complications and mortality.
No takes yet. Share an insight, caveat, or question.
Tafese et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: